Zynex, Inc. (ZYXIQ)

Market Cap	1.69M -98.4%
Revenue (ttm)	108.20M -44.1%
Net Income	-73.96M
EPS	-2.39
Shares Out	30.78M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	274,571
Open	0.0500
Previous Close	0.0520
Day's Range	0.0500 - 0.0650
52-Week Range	0.0203 - 2.8200
Beta	1.08
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 12, 2026

About Zynex

Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain, and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology de...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1996
• Employees: 1,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ZYXIQ

Financial Performance

In 2024, Zynex's revenue was $192.35 million, an increase of 4.36% compared to the previous year's $184.32 million. Earnings were $2.99 million, a decrease of -69.24%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Mar 28, 2026

Data Sources Report a data error